Latest News about AZN
Recent news which mentions AZN
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
From Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
From Motley Fool
Could This Be Novartis' Next Blockbuster Medicine?
January 27, 2023
From Motley Fool
7 Dividend Stocks to Buy for a Stable Income Stream
January 27, 2023
From InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
From Motley Fool
The Top Healthcare Stocks to Buy With $100
January 23, 2023
From Motley Fool
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
January 18, 2023
From MarketWatch
3 Growth Stocks Poised for Huge Gains in 2023
January 14, 2023
From Motley Fool
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
From Motley Fool
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
Could This New Drug Launch Be a Hit for Viatris?
January 12, 2023
From Motley Fool
From Benzinga
Why Is CinCor (CINC) Stock Up 138% Today?
January 09, 2023
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From MarketWatch
Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
January 09, 2023
From MarketWatch
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
January 09, 2023
From MarketWatch
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
From Motley Fool
AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says
January 05, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
3 Top Healthcare Stocks Defying the Bear Market
January 03, 2023
From Motley Fool
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
January 03, 2023
From Benzinga
Why Shares of Compugen Rose on Thursday
December 29, 2022
From Motley Fool
Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang
December 26, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
